These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25428381)

  • 21. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
    Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
    Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of ILK and ERP29 expressions in benign and malignant pancreatic lesions and their clinicopathological significances in pancreatic ductal adenocarcinomas.
    Zhang K; Yao H; Yang Z; Li D; Yang L; Zou Q; Yuan Y; Miao X
    Clin Transl Oncol; 2016 Apr; 18(4):352-9. PubMed ID: 26887611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High expression of RAB27A and TP53 in pancreatic cancer predicts poor survival.
    Wang Q; Ni Q; Wang X; Zhu H; Wang Z; Huang J
    Med Oncol; 2015 Jan; 32(1):372. PubMed ID: 25428385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma.
    Foo WC; Rashid A; Wang H; Katz MH; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Fleming JB; Wang H
    Hum Pathol; 2013 Jun; 44(6):1024-30. PubMed ID: 23260327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of laminin subunit alpha 3 expression in pancreatic ductal adenocarcinoma with tumor liver metastasis and survival.
    Xing Y; Jing X; Qing G; Jiang Y
    Radiol Oncol; 2024 Jun; 58(2):234-242. PubMed ID: 38452390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients.
    Hu J; Hu H; Hang JJ; Yang HY; Wang ZY; Wang L; Chen DH; Wang LW
    Oncotarget; 2016 Nov; 7(48):78557-78565. PubMed ID: 27713167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Zhou X; Wang X; Duan J; Sun W; Chen Z; Li Q; Ou Z; Jiang G; Ren X; Liu S
    Pathol Res Pract; 2019 Feb; 215(2):343-346. PubMed ID: 30583814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BIRC7 and KLF4 expression in benign and malignant lesions of pancreas and their clinicopathological significance.
    Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2016; 17(4):437-444. PubMed ID: 27802195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of B2M and loss of ALK7 expression are associated with invasion, metastasis, and poor-prognosis of the pancreatic ductal adenocarcinoma.
    Liu C; Yang Z; Li D; Liu Z; Miao X; Yang L; Zou Q; Yuan Y
    Cancer Biomark; 2015; 15(6):735-43. PubMed ID: 26406402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
    Sun J; Bi F; Yang Y; Zhang Y; Jin A; Li J; Lin Z
    Oncol Rep; 2017 Feb; 37(2):857-864. PubMed ID: 27959420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ataxia-telangiectasia-mutated protein kinase levels stratify patients with pancreatic adenocarcinoma into prognostic subgroups with loss being a strong indicator of poor survival.
    Kamphues C; Bova R; Bahra M; Klauschen F; Muckenhuber A; Sinn BV; Warth A; Goeppert B; Endris V; Neuhaus P; Weichert W; Stenzinger A
    Pancreas; 2015 Mar; 44(2):296-301. PubMed ID: 25423555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stromal fibronectin expression in patients with resected pancreatic ductal adenocarcinoma.
    Hu D; Ansari D; Zhou Q; Sasor A; Said Hilmersson K; Andersson R
    World J Surg Oncol; 2019 Feb; 17(1):29. PubMed ID: 30736807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTEN/PI3K/AKT protein expression is related to clinicopathological features and prognosis in breast cancer with axillary lymph node metastases.
    Wang LL; Hao S; Zhang S; Guo LJ; Hu CY; Zhang G; Gao B; Zhao JJ; Jiang Y; Tian WG; Wang J; Luo DL
    Hum Pathol; 2017 Mar; 61():49-57. PubMed ID: 27864123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AHNAK2 is a potential prognostic biomarker in patients with PDAC.
    Lu D; Wang J; Shi X; Yue B; Hao J
    Oncotarget; 2017 May; 8(19):31775-31784. PubMed ID: 28423668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas.
    Jia N; Dong S; Zhao G; Gao H; Li X; Zhang H
    J Cancer Res Ther; 2016; 12(2):892-6. PubMed ID: 27461670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of CD44 in pancreatic cancer and its significance.
    Li XP; Zhang XW; Zheng LZ; Guo WJ
    Int J Clin Exp Pathol; 2015; 8(6):6724-31. PubMed ID: 26261555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The combination of a nuclear HMGB1-positive and HMGB2-negative expression is potentially associated with a shortened survival in patients with pancreatic ductal adenocarcinoma.
    Takeda T; Izumi H; Kitada S; Uramoto H; Tasaki T; Zhi L; Guo X; Kawatsu Y; Kimura T; Horie S; Nabeshima A; Noguchi H; Wang KY; Sasaguri Y; Kohno K; Yamada S
    Tumour Biol; 2014 Oct; 35(10):10555-69. PubMed ID: 25060178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic significance of XB130 expression in surgically resected pancreatic ductal adenocarcinoma.
    Zhang J; Jiang X; Zhang J
    World J Surg Oncol; 2014 Mar; 12():49. PubMed ID: 24581082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological significance of ASC amino acid transporter-2 expression in pancreatic ductal carcinoma.
    Kaira K; Sunose Y; Arakawa K; Sunaga N; Shimizu K; Tominaga H; Oriuchi N; Nagamori S; Kanai Y; Oyama T; Takeyoshi I
    Histopathology; 2015 Jan; 66(2):234-43. PubMed ID: 24845232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.
    Martinez-Useros J; Georgiev-Hristov T; Fernández-Aceñero MJ; Borrero-Palacios A; Indacochea A; Guerrero S; Li W; Cebrián A; Gómez Del Pulgar T; Puime-Otin A; Del Puerto-Nevado L; Rodríguez-Remírez M; Pérez N; Celdrán A; Gebauer F; Garcia-Foncillas J
    PLoS One; 2017; 12(8):e0182044. PubMed ID: 28763470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.